Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00365820 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain
A Phase 2 study, sponsored by Novartis.
- Terminated
- Registry status
- Phase 2
- Development phase
- 670
- Enrollment target
NCT00365820: Clinical Trial Phase 2 study, sponsored by Novartis.
NCT00365820 is a Phase 2 study that was terminated before completion, run by Novartis. The registered enrollment target is 670 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (404% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00365820, a Phase 2 study, was terminated before completion, sponsored by Novartis.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 670 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and safety of tegaserod in opioid-induced constipation in patients with non-cancer pain.
Interventions
- DRUG Tegaserod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 670 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
Why NCT00365820 stopped before completion
NCT00365820 is an interventional study that assigns participants to a tested intervention. The registered 670 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (404% higher).
The record links to 0 conditions, and to 1 intervention - of which Tegaserod is the first listed.
NCT00365820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00365820 about?
NCT00365820 is a clinical study titled "Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain". This study will evaluate the efficacy and safety of tegaserod in opioid-induced constipation in patients with non-cancer pain.
What is the current status of trial NCT00365820?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 670 participants. The study started on 2006-07. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00365820?
The interventions under investigation include: Tegaserod (DRUG).
Who is sponsoring clinical trial NCT00365820?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00365820's enrollment target sits among peer trials
670 48th of 2000 higher than 1,953 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02984761 · 670 participants · NA
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- NCT05727904 · 670 participants · Phase 3
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- NCT06223867 · 670 participants · NA
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia